Kotak Investment Advisors Limited (KIAL), the alternative assets arm of Kotak Mahindra Group, on Tuesday said it has invested up to Rs 400 crore ($47.9 million) in medical device manufacturer Biorad Medisys, through its Strategic Situations India Fund II.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
